MIR660 (microRNA 660; HGNC:32916, NCBI Gene 724030) at Xp11.23 encodes miR-660 — an X-linked microRNA with a review-level cancer file ("a novel regulator in human cancer pathogenesis"): breast-cancer progression through TET2 down-regulation and PI3K/AKT/mTOR activation, hepatocellular and lung contexts, an exosomal transfer file, and a neuronal-protection report through APP targeting in Alzheimer's models.
Approved Symbol
MIR660 (HGNC:32916)
Chromosomal Locus
Xp11.23
Encoded Product
A 22-nt mature microRNA (the 5p arm the cited file)
Multi-cancer regulator file; exosomal transfer; the Alzheimer's APP report
Gene Structure & Expression
Structure: The single Xp11.23 hairpin; the band carries several microRNA loci and the X-linked cohort's tumor-expression literature applies.
Expression: The 5p arm across the cancer panels; exosome-mediated transfer the distribution file — macrophage-derived vesicles a reported source in the hepatocellular context.
Molecular Function & Pathways
Epigenetic arm: miR-660-5p reported to promote breast-cancer progression through TET2 (the demethylase) down-regulation with PI3K/AKT/mTOR activation — an microRNA-epigenetics crossover acting on AKT1's route (see nucleic acids for the methylation context).
Neuronal arm: miR-660-5p reported to ameliorate neuronal damage in Alzheimer's-disease models through APP targeting — a non-oncology file most X-linked tumor microRNAs lack (see brain).
Clinical & Therapeutic Significance
Biomarker: The multi-cancer review file's panels; exosomal miR-660-5p in non-small-cell lung cancer reported to promote tumor growth and metastasis.
Therapeutic direction: The review's framing — a regulator with therapeutic implications, the anti-miR concept in the PI3K-route contexts.